Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
09/1994
09/29/1994CA2158748A1 Botulinum toxin polypeptides and their use as vaccine enhancing agents
09/28/1994EP0617127A1 Antigenic epitopes on B cell-bound IgE Immunoglobulins
09/28/1994EP0616613A1 Fragments of prion proteins
09/28/1994EP0539486B1 Process for the preparation of streptogramine derivatives
09/28/1994EP0467998B1 Peptides from retinoblastoma gene products and antibodies thereto
09/28/1994EP0222835B1 Oral vaccines
09/27/1994US5350574 Immunosuppressive agent for preventing organ rejection
09/21/1994EP0615522A1 Muramyl compounds for treatment of septic shock
09/21/1994EP0440688B1 Cpf peptide compositions and uses
09/20/1994US5349050 Peptides, and antidementia agents containing the same
09/20/1994US5348940 Fungicidal antibiotics
09/15/1994WO1994020622A1 Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus
09/15/1994WO1994020615A1 Bone stimulating factor
09/15/1994WO1994020532A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
09/15/1994WO1994020531A1 Physiologically active peptide
09/15/1994WO1994020530A2 Neuropeptides and their use as insecticides
09/15/1994WO1994020529A1 Osteogenic growth oligopeptides and pharmaceutical compositions containing them
09/15/1994WO1994020528A1 Inhibitors of herpes viral ribonucleotide reductase
09/15/1994WO1994020128A1 Therapeutic uses of bactericidal/permeability increasing protein products
09/15/1994WO1994020127A1 Hla-a2.1 binding peptides and their uses
09/15/1994WO1994020126A1 Use of peptides for the manufacture of a medicament
09/15/1994WO1994017192A3 Lysosomal targeting of immunogens
09/15/1994WO1994011394A3 Peptides with organo-protective activity, process for their preparation and their use in the therapy
09/15/1994WO1994004688A3 Cationic peptides and method for production
09/15/1994CA2157901A1 Bone stimulating factor
09/15/1994CA2157510A1 Hla-a2.1 binding peptides and their uses
09/14/1994EP0614982A1 Recombinant vector for the exocellular preparation of single chain antibodies expressed in bacillus subtilis
09/14/1994EP0614975A1 Glycoprotein hormone receptor molecules
09/14/1994EP0614913A2 Dynorphin derivatives
09/14/1994EP0614910A1 Streptogramines in purified form, their preparation and pharmaceutical compositions comprising them
09/14/1994EP0614666A1 Lyophilized polyalkylene oxide modified protein and polypeptide complexes with cyclodextrin
09/14/1994EP0614464A1 Peptides and antibodies for treatment of rheumatoid arthritis
09/14/1994EP0614379A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING
09/14/1994EP0614369A1 Pharmaceutical dipeptide compositions and methods of use thereof
09/13/1994US5346989 Peptides for use in induction of T cell activation against HIV-1
09/12/1994CA2118661A1 Acyloxyhexanoic acid derivatives
09/07/1994EP0613375A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof
09/07/1994CN1091746A Synthetic peptides derived from vitronectin and pharmaceutical compositions them
09/07/1994CN1025860C Cross reactive and protective epitope of cicumsporozoite proteins
09/06/1994US5344915 Proteins and the preparation thereof
09/06/1994US5344913 Biodegradable; high strength detergent
09/01/1994WO1994019372A1 Cyclic bradykinin antagonist peptides
09/01/1994WO1994019370A1 Gnrh antagonists
09/01/1994WO1994019024A2 TECHNETIUM-99m LABELED PEPTIDES FOR DIAGNOSTIC IMAGING
09/01/1994WO1994019011A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
09/01/1994WO1994015637A3 Prevention of suppression of immune defense against cancer caused by the cancer-associated scm-recognition peptides
09/01/1994WO1994015587A3 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
09/01/1994DE4406491A1 Cleavage apparatus
09/01/1994CA2594184A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
08/1994
08/31/1994EP0612763A1 Cyclic derivatives of angiopeptin, their preparation and their pharmaceutical compositions
08/31/1994EP0612762A1 Elucidation and synthesis of selected pentapeptides
08/31/1994EP0502987B1 Acylated bradykinin antagonists and uses therefor
08/31/1994EP0476014B1 Very large scale immobilized polymer synthesis
08/31/1994CN1091470A Unreductases produced of saccharide preparation and application of same
08/30/1994US5342922 Inhibitors of retroviral protease
08/30/1994US5342774 Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1
08/26/1994CA2106519A1 Lyophilized polyethylene oxide modified protein and polypeptide complexes with cyclodextrin
08/24/1994EP0611774A1 Production of amides and peptides without racemization in the presence of catalytic amounts of a N-hydroxy-compound
08/24/1994EP0611572A2 Process to prepare a cetrorelix lyophilised composition
08/24/1994EP0611375A1 Peptides inhibiting il-1 beta release
08/24/1994EP0564587A4 Solution phase process for synthesis of peptide
08/24/1994EP0359745B1 Growth factor receptor
08/24/1994EP0314755B1 Use of derivatives of GHL-Cu for the manufacture of a medicament for stimulating hair growth
08/24/1994CN1091138A Vaccines
08/23/1994US5340800 Peptide medicaments for the treatment of disease
08/23/1994US5340727 GPIbα fragments and recombinant DNA expression vectors
08/23/1994US5340474 Panels of analyte-binding ligands
08/23/1994CA2115972A1 Cyclopeptide derivatives of angiopeptin, process for the preparation thereof and pharmaceutical compositions containing same
08/21/1994CA2115966A1 Chrysospermins, active peptides from apiocrea chrysosperma having a pharmacological effect, a process for their preparation and the use thereof
08/18/1994WO1994018324A2 Phospho-specific antibodies against transcription factors, more specifically against a creb derived peptide
08/18/1994WO1994018322A1 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS
08/18/1994WO1994018317A1 Regulated transcription of targeted genes and other biological events
08/18/1994WO1994018235A1 Novel cyclic pentapeptide
08/18/1994WO1994018230A1 Inhibition of hiv replication by peptide-copper complexes
08/18/1994CA2155646A1 Phospho-specific antibodies against a creb derived peptide
08/18/1994CA2115807A1 Purified form of streptogramins, its preparation and pharmaceutical compositions containing same
08/17/1994EP0610475A1 Enzymatically-produced dimeric il-2 and a nerve-derived transglutaminase enzyme for its preparation
08/17/1994EP0610201A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
08/16/1994US5338726 Endothelin converting enzyme inhibitors
08/16/1994US5338725 Anti-aggregatory agents for platelets
08/16/1994US5338668 Opioid peptides derived from wheat proteins
08/16/1994US5338663 Interferes with formation of specific complex between alpha-antichymotrypsin and beta-protein; hydrolysis of substrate does not occur
08/16/1994CA1331499C Amino acids and peptides having a modified tyrosine residue, their preparation and their application as medicaments
08/10/1994EP0610078A1 Cytotoxic and antiviral compound
08/10/1994CN1090584A Synthetic polypeptides
08/10/1994CN1090509A Pharmaceutical composition
08/09/1994US5336758 AIDS vaccines
08/09/1994US5336757 Antibacterial peptide and methods of use
08/09/1994US5336756 Dissolving in propanol allowing to crystallize
08/06/1994WO1994017820A1 Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same
08/06/1994CA2126455A1 Liver fluke vaccine and polypeptides useful for same
08/04/1994WO1994017192A2 Lysosomal targeting of immunogens
08/04/1994WO1994017095A1 Analogs of receptor tyrosine activation motifs and therapeutic uses thereof
08/04/1994WO1994016717A1 Method of treating diabetes mellitus
08/03/1994EP0608696A2 Heterologous signal sequences for secretion of insect controlling proteins
08/03/1994EP0608260A1 Peptide inhibitors of inflammation mediated by selectins
08/03/1994CN1090201A Angiotensin converting enzyme inhibitor and method for preparing same
08/02/1994US5334702 Compositions which are immunologically crossreactive with antibodies and preparative methods therefor
08/02/1994US5334382 Lyophilized polyethylene oxide modified catalase composition, polypeptide complexes with cyclodextrin and treatment of diseases with the catalase compositions
08/02/1994CA1331156C Haloarylnitrile degrading gene, its use, and cells containing the gene